Atovaquone-proguanil 250-100 100S
Ended Awarded
- Contract number
- SPE2DB25FN3WQ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,249
Award facts
- Contract value 100% obligated
- $2,248.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $2,248.56 delivery order to AmerisourceBergen Drug Corp for Atovaquone-Proguanil 250-100 tablets (100-count supply). The contract, which is firm fixed price with no set-aside designation, was awarded on August 18, 2025, and is scheduled for completion by August 19, 2025. Performance will be executed at AmerisourceBergen's Conshohocken, Pennsylvania location. This delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 vehicle valued through December 2026 that serves as a comprehensive global pharmaceutical support mechanism for military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is a critical federal medical procurement vendor serving military and veteran healthcare systems. The Atovaquone-Proguanil delivery represents one of numerous pharmaceutical procurements through the DLA Medical Supply Chain, where the company supplies an extensive portfolio including brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The competitively awarded delivery order reflects AmerisourceBergen's established capability to fulfill federal pharmaceutical requirements efficiently and demonstrates the company's role as a key provider within the Defense Health Agency's pharmaceutical support infrastructure.
Quick answers
Who was awarded contract SPE2DB25FN3WQ?
SPE2DB25FN3WQ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 18, 2025.
How much is contract SPE2DB25FN3WQ worth?
The government has obligated $2,249 on SPE2DB25FN3WQ.
Is contract SPE2DB25FN3WQ an order under another contract?
Yes. SPE2DB25FN3WQ is a delivery order under SPE2DB22D1200, an indefinite delivery contract.
Was contract SPE2DB25FN3WQ competed?
The extent of competition for SPE2DB25FN3WQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award